Cargando…
Identifying Rare Genetic Variants of Immune Mediators as Risk Factors for Autism Spectrum Disorder
Autism spectrum disorder (ASD) affects more than 1% of children, and there is no viable pharmacotherapeutic agent to treat the core symptoms of ASD. Studies have shown that children with ASD show changes in their levels of immune response molecules. Our previous studies have shown that ASD is more c...
Autores principales: | Cai, Chunquan, Yin, Zhaoqing, Liu, Aiping, Wang, Hui, Zeng, Shujuan, Wang, Zhangxing, Qiu, Huixian, Li, Shijun, Zhou, Jiaxiu, Wang, Mingbang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223212/ https://www.ncbi.nlm.nih.gov/pubmed/35741860 http://dx.doi.org/10.3390/genes13061098 |
Ejemplares similares
-
Dendritic Spine in Autism Genetics: Whole-Exome Sequencing Identifying De Novo Variant of CTTNBP2 in a Quad Family Affected by Autism Spectrum Disorder
por: Xie, Yingmei, et al.
Publicado: (2022) -
Virulence factor-related gut microbiota genes and immunoglobulin A levels as novel markers for machine learning-based classification of autism spectrum disorder
por: Wang, Mingbang, et al.
Publicado: (2020) -
Alterations in Gut Glutamate Metabolism Associated with Changes in Gut Microbiota Composition in Children with Autism Spectrum Disorder
por: Wang, Mingbang, et al.
Publicado: (2019) -
Machine learning approach identifies meconium metabolites as potential biomarkers of neonatal hyperbilirubinemia
por: Zeng, Shujuan, et al.
Publicado: (2022) -
Altered Urinary Amino Acids in Children With Autism Spectrum Disorders
por: Liu, Aiping, et al.
Publicado: (2019)